ARTICLE | Company News
Biolife Science, Imugene deal
January 13, 2014 8:00 AM UTC
Imugene completed its acquisition of Biolife for 300 million shares of Imugene stock, or about A$4.5 million ($4 million) based on Imugene's close of A$0.015 on Dec. 18, before the deal closed (see Bi...